Aclarion, Inc.(ACON)
Health Care Technology
Clinical Decision Support
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | Breidbart Scott Director | Purchase | +5,664 | +100.00%5,664 | $3.18 | $18,012 | View SEC filing | |
| 2026-05-12 | Neal David K Director | Purchase | +2,500 | +125000.00%2,502 | $3.10 | $7,750 | View SEC filing | |
| 2026-05-11 | Ness Brent Chief Executive Officer | Purchase | +6,289 | +57172.73%6,300 | $3.18 | $19,999 | View SEC filing | |
| 2026-05-08 | Wesemann William Director | Purchase | +1,562 | +156200.00%1,563 | $3.30 | $5,155 | View SEC filing | |
| 2025-12-01 | Ness Brent Chief Executive Officer | Purchase | +10 | +1000.00%11 | $6.20 | $62 | View SEC filing | |
| 2023-02-21 | Thramann Jeffrey John Executive Chairman | Purchase | +1 | +100.00%1 | $1000.00 | $1,000 | View SEC filing | |
| 2022-12-29 | Ness Brent Chief Executive Officer | Purchase | +18,500 | +1850.00%19,500 | $0.53 | $9,769 | View SEC filing | |
| 2022-12-29 | Lorbiecki John Paul Chief Financial Officer | Purchase | +22,404.441 | +100.00%22,404.411 | $0.45 | $10,000 | View SEC filing | |
| 2022-04-25 | Wesemann William Director | Purchase | +22,000 | +42.49%73,776 | $2.17 | $47,850 | View SEC filing | |
| 2022-04-25 | Ness Brent Chief Executive Officer | Purchase | +2,000 | +0.59%343,365 | $2.17 | $4,350 | View SEC filing | |
| 2022-04-25 | Neal David K Director | Purchase | +68,800 | +97.89%139,081 | $2.17 | $149,640 | View SEC filing | |
| 2022-04-25 | Bond Ryan Chief Strategy Officer | Purchase | +41,000 | +148.94%68,527 | $1.74 | $71,330 | View SEC filing |
1-12 of 12